Baxter International Inc (BAX) : Sawtooth Asset Management scooped up 1,924 additional shares in Baxter International Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 22,943 shares of Baxter International Inc which is valued at $1,114,800.Baxter International Inc makes up approximately 0.58% of Sawtooth Asset Management’s portfolio.
Other Hedge Funds, Including , A.r.t. Advisors sold out all of its stake in BAX during the most recent quarter. The investment firm sold 110,479 shares of BAX which is valued $5,368,175.Apg Asset Management N.v. boosted its stake in BAX in the latest quarter, The investment management firm added 612,412 additional shares and now holds a total of 2,930,138 shares of Baxter International Inc which is valued at $142,375,405. Baxter International Inc makes up approx 0.26% of Apg Asset Management N.v.’s portfolio.Blackhill Capital Inc reduced its stake in BAX by selling 3,000 shares or 2.25% in the most recent quarter. The Hedge Fund company now holds 130,200 shares of BAX which is valued at $6,257,412. Baxter International Inc makes up approx 1.00% of Blackhill Capital Inc’s portfolio.Parkside Financial Bank Trust reduced its stake in BAX by selling 13 shares or 1.76% in the most recent quarter. The Hedge Fund company now holds 727 shares of BAX which is valued at $34,983. Baxter International Inc makes up approx 0.02% of Parkside Financial Bank Trust’s portfolio.Tokio Marine Asset Management Co Ltd reduced its stake in BAX by selling 855 shares or 5.04% in the most recent quarter. The Hedge Fund company now holds 16,123 shares of BAX which is valued at $779,063. Baxter International Inc makes up approx 0.08% of Tokio Marine Asset Management Co Ltd’s portfolio.
Baxter International Inc closed down -0.55 points or -1.18% at $46.18 with 42,49,317 shares getting traded on Thursday. Post opening the session at $46.75, the shares hit an intraday low of $45.91 and an intraday high of $46.78 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Baxter International Inc reported $0.46 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 26, 2016. Analyst had a consensus of $0.40. The company had revenue of $2585.00 million for the quarter, compared to analysts expectations of $2516.16 million. The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Baxter International Inc. Company shares were Reiterated by RBC Capital Mkts on Jul 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 50 from a previous price target of $47 .Baxter International Inc was Resumed by JP Morgan to “Neutral” on Jun 6, 2016.
Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.